ArticleRespirology case reports2026

Systemic AL (λ) Amyloidosis Discovered After Neoadjuvant Pembrolizumab-Based Chemoimmunotherapy for Resectable NSCLC: Case Report.

Weijie Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.